Physician profile
William A Condrell
NPI 1770643280
$534.02
in general payments reported to CMS, 2019-2025
17 companies · $53.00 in 2025
The $53.00 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $107 · 2021: $81.55 · 2022: $41.29 · 2023: $59.63 · 2024: $64.48 · 2025: $53.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $124.49 | 2019-2022 | |
| Pfizer INC. | $104.24 | 2020-2025 | |
| Astrazeneca Pharmaceuticals Lp | $31.13 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $28.12 | 2022 | |
| Sunovion Pharmaceuticals INC. | $27.98 | 2019 | |
| Medtronic, INC. | $25.89 | 2024 | Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.54 | 2024 | Xifaxan |
| Exact Sciences Corporation | $21.31 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $20.89 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $19.45 | 2019 | |
| Glaxosmithkline, LLC. | $17.43 | 2023 | Arexvy |
| Jazz Pharmaceuticals INC. | $16.52 | 2020 | |
| Astellas Pharma US INC | $16.05 | 2024 | Veozah |
| Lilly USA, LLC | $15.16 | 2025 | Zepbound, Mounjaro |
| Arbor Pharmaceuticals, INC. | $15.02 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $14.82 | 2025 | |
| Livanova USA, INC. | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Condrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.